Researchers mapped more than 100 mutations that allow diverse HIV-1 strains to evade broadly neutralizing antibodies.

A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

EnGene (NASDAQ: ENGN) stock suffered a more-than-80% plunge this past week that reflects just how competitive the field is ...

The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

There is no margin for error in the pharma and biopharma sectors. If the chain-identity breaks anywhere along the way, there ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...

Macrophages use cell‑volume changes to sense danger, reprogram gene expression, and heighten inflammatory and antiviral ...

Enein, MD, PhD, for a measurement-driven approach that advances cell therapy translation, from high-dimensional analytics to ...

Bayer has agreed to acquire Perfuse Therapeutics for up to $2.45 billion, in a deal designed to broaden the buyer’s ophthalmology pipeline with Perfuse’s sole pipeline drug and two clinical phase ...

Erasca's share price nosedived 53% after a patient died in its Phase I trial of ERAS-0015, and rival Revolution Medicine ...

For the second year in a row, GEN spoke with David Barrett, JD, who has been the CEO of ASGCT since 2016. In this interview, ...